Cargando...
New Progress of Epigenetic Biomarkers in Urological Cancer
Urological cancers consist of bladder, kidney, prostate, and testis cancers and they are generally silenced at their early stage, which leads to the loss of the best opportunity for early diagnosis and treatment. Desired biomarkers are scarce for urological cancers and current biomarkers are lack of...
Guardado en:
| Publicado en: | Dis Markers |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Hindawi Publishing Corporation
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4993951/ https://ncbi.nlm.nih.gov/pubmed/27594736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9864047 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|